Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results. 18 May 2018 Investors in Idera Pharmaceuticals (IDRA) need to pay close attention to the stock based on moves in the options market lately. 10 May 2019 The stock has moved higher by 25% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance 

Idera Pharmaceuticals, Inc. (IDRA) Latest Stock News ... Get the latest Idera Pharmaceuticals, Inc. (IDRA) stock news and headlines to help you in your trading and investing decisions. Zacks. Idera Completes Recruitment in Late-Stage Melanoma Study. IDRA Stock Price | Idera Pharmaceuticals Inc. Stock Quote ... IDRA | Complete Idera Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

IDRA Stock Quotes API Business Summary Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines.

Idera Phamaceuticals (IDRA) Stock Jumping Following New Coverage. By Kurumi Fukushima. Jun 15, 2015 11:01 AM EDT. STOCKS. Analysts' Actions -- EMC, Lowe's, Micron and More. By TheStreet Staff. Options Traders Expect Huge Moves In Idera Pharmaceuticals ... Stocks Analysis by Zacks Investment Research covering: Netflix Inc, Idera Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com. Breaking News. Idera Pharmaceuticals - 24 Year Stock Price History | IDRA ... Historical daily share price chart and data for Idera Pharmaceuticals since 1996 adjusted for splits. The latest closing stock price for Idera Pharmaceuticals as of March 13, 2020 is 1.18.. The all-time high Idera Pharmaceuticals stock closing price was 4361.60 on January 31, 1996.; The Idera Pharmaceuticals 52-week high stock price is 4.19, which is 255.1% above the current share price. IDRA - Idera Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time IDRA - Idera Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

IDRA Stock Quotes API Business Summary Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines.

BMC STOCK HOLDINGS INC. BMCH IDERA PHARMACEUTICALS INC. IDRA. INDUSTRIAL SVCS OF AMERICA KRANESHARES ZACKS NEW CHINA. 19 Dec 2019 An initial public offering is when a company offers shares of stock or debt securities to the public for the first time to raise capital. On the other  Idera Pharmaceuticals, Inc. - IDRA - Stock Price Today - Zacks View Idera Pharmaceuticals, Inc. IDRA investment & stock information. Get the latest Idera Pharmaceuticals, Inc. IDRA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Idera Pharmaceuticals (NASDAQ:IDRA) Upgraded to “Buy” at ...

Idera Pharmaceuticals, Inc. (“Idera” or “the company”) (IDRA) today announced completion of patient enrollment into ILLUMINATE-301, its registrational trial of tilsotolimod in combination with ipilimumab in patients with anti-PD-1 refractory advanced melanoma. IDRA | Idera Pharmaceuticals Inc. Profile | MarketWatch Nov 04, 2019 · Idera Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View idra business summary and other industry information. Zacks: Analysts Expect Idera Pharmaceuticals Inc (NASDAQ ...

10 May 2019 The stock has moved higher by 25% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance 

Idera Pharmaceuticals, Inc. (“Idera” or “the company”) (IDRA) today announced completion of patient enrollment into ILLUMINATE-301, its registrational trial of tilsotolimod in combination with ipilimumab in patients with anti-PD-1 refractory advanced melanoma. IDRA | Idera Pharmaceuticals Inc. Profile | MarketWatch Nov 04, 2019 · Idera Pharmaceuticals Inc. company facts, information and stock details by MarketWatch. View idra business summary and other industry information. Zacks: Analysts Expect Idera Pharmaceuticals Inc (NASDAQ ... Wall Street analysts forecast that Idera Pharmaceuticals Inc (NASDAQ:IDRA) will report earnings of ($0.33) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Idera Pharmaceuticals - IDRA - Stock Price & News | The ... Real time Idera Pharmaceuticals (IDRA) stock price quote, stock graph, news & analysis. Real time Idera Pharmaceuticals (IDRA) stock price quote, stock graph, news & analysis.

Find the latest Idera Pharmaceuticals, Inc. (IDRA) stock quote, history, news and other vital information to help you with your stock trading Zacks•last month  5 hours ago Idera Pharmaceuticals Inc. (IDRA) has sold shares of common stock The common stock warrants, if issued, will have an exercise price of $2.71 per The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co,  2020-02-25 $ 8.9 (-10.91%). 8:41am. Is the Options Market Predicting a Spike in Akebia Therapeutics (AKBA) Stock? - www.zacks.com. 2020-01-06 $ 6.62 (3.44  Idera Pharma (IDRA) Stock Holds its Own After PPM Announcement Soligenix (NASDAQ: SNGX) stock got a boost on Tuesday after Zacks Small Cap